| __timestamp | GSK plc | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8246000000 | 2917513 |
| Thursday, January 1, 2015 | 9232000000 | 7878291 |
| Friday, January 1, 2016 | 9366000000 | 8366794 |
| Sunday, January 1, 2017 | 9672000000 | 6610381 |
| Monday, January 1, 2018 | 9915000000 | 6556000 |
| Tuesday, January 1, 2019 | 11402000000 | 6930000 |
| Wednesday, January 1, 2020 | 11456000000 | 8758000 |
| Friday, January 1, 2021 | 10975000000 | 10806000 |
| Saturday, January 1, 2022 | 8372000000 | 9844000 |
| Sunday, January 1, 2023 | 9385000000 | 13481000 |
Unleashing insights
In the ever-evolving landscape of pharmaceuticals, effective cost management is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of GSK plc and Soleno Therapeutics, Inc. from 2014 to 2023. GSK, a global healthcare giant, consistently reported SG&A expenses averaging around $9.8 billion annually, with a peak in 2020. In contrast, Soleno Therapeutics, a smaller player, averaged $8.2 million, reflecting its leaner operations. Notably, Soleno's expenses surged by 362% from 2014 to 2023, indicating strategic investments in growth. Meanwhile, GSK's expenses fluctuated, highlighting its adaptive strategies in a competitive market. This comparison underscores the diverse financial strategies within the pharmaceutical sector, where scale and agility play pivotal roles in shaping financial outcomes.
Selling, General, and Administrative Costs: Johnson & Johnson vs Soleno Therapeutics, Inc.
GSK plc vs Catalent, Inc.: SG&A Expense Trends
GSK plc or Verona Pharma plc: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: GSK plc vs ACADIA Pharmaceuticals Inc. Trends and Insights
Breaking Down SG&A Expenses: GSK plc vs Veracyte, Inc.
Cost Management Insights: SG&A Expenses for Insmed Incorporated and Soleno Therapeutics, Inc.
BioMarin Pharmaceutical Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Perrigo Company plc vs Soleno Therapeutics, Inc. Trends and Insights
ImmunityBio, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Ligand Pharmaceuticals Incorporated and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Soleno Therapeutics, Inc. vs MannKind Corporation
Selling, General, and Administrative Costs: Soleno Therapeutics, Inc. vs Xencor, Inc.